Emollient formulations containing antiseptics reduce effectively the level of Staphylococcus aureus on skin

References

• Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90(5):525–530. doi:10.1111/j.1365-2133.1974.tb06447.x4601016
   PubMed Web of Science ®Google Scholar
• Hauser C, Wuethrich B, Matter L, Wilhelm JA, Sonnabend W, Schopfer K. Staphylococcus aureus skin colonization in atopic dermatitis. Dermatologica. 1985;170(1):35–39. doi:10.1159/0002494933972149
   PubMedGoogle Scholar
• Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol. 1977;113(6):780–782. doi:10.1001/archderm.1977.01640060076008141239
   PubMedGoogle Scholar
• Cole GW, Silverberg NL. The adherence of Staphylococcus aureus to human corneocytes. Arch Dermatol. 1986;122(2):166–169. doi:10.1001/archderm.1986.016601400560172418794
   PubMedGoogle Scholar
• Ong PY, Ohtake T, Brandt C, et al Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347(15):1151–1160. doi:10.1056/NEJMoa02148112374875
   PubMed Web of Science ®Google Scholar
• Higaki S, Morohashi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999;38(4):265–269. doi:10.1046/j.1365-4362.1999.00686.x10321941
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Bzowska M, Kasprowicz A, et al Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy. 2005;35(4):448–455. doi:10.1111/j.1365-2222.2005.02210.x15836752
   PubMed Web of Science ®Google Scholar
• Zollner TM, Wichelhaus TA, Hartung A, et al Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy. 2000;30(7):994–1000. doi:10.1046/j.1365-2222.2000.00848.x|10848922
   PubMed Web of Science ®Google Scholar
• Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol. 1998;119(2):189–198. doi:10.1111/j.1365-2133.1988.tb03201.x
   Web of Science ®Google Scholar
• Breuer K, Häussler S, Kappa T, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol. 2002;147(1):55–61. doi:10.1046/j.1365-2133.2002.04872.x12100185
   PubMed Web of Science ®Google Scholar
• Schnopp C, Ring J, Mempel M. The role of antibacterial therapy in atopic eczema. Expert Opin Pharmacother. 2010;11(6):929–936. doi:10.1517/1465656100365999220307218
   PubMed Web of Science ®Google Scholar
• Lee M, Van Bever H. The role of antiseptic agents in atopic dermatitis. Asia Pac Allergy. 2014;4(4):230–240. doi:10.5415/apallergy.2014.4.4.23025379483
   PubMedGoogle Scholar
• Rajka G. Emollient therapy in atopic dermatitis. J Dermatol Treat. 1997;8(Suppl 1):S19–S21. doi:10.3109/09546639709160942
   Web of Science ®Google Scholar
• Cork MJ. The importance of skin barrier function. J Dermatol Treat. 1997;8(Suppl 1):S7–S13. doi:10.3109/09546639709160948
   Web of Science ®Google Scholar
• Lucky AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid sparing in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997;14(4):321–324. doi:10.1111/j.1525-1470.1997.tb00968.x|9263319
   PubMed Web of Science ®Google Scholar
• Whitefield M. Effectiveness of a new antimicrobial emollient in the management of eczema/dermatitis. J Dermatol Treat. 1998;9(2):103–109. doi:10.3109/09546639809161381
   Web of Science ®Google Scholar
• BS EN 1499:1997. Chemical Disinfectants and Antiseptics. Hygienic Handwash. Test Methods and Requirements (phase 2/step 2). London, UK: British Standards Institute; 1997.
   Google Scholar
• Spada F, Barnes TM, Greive KA. Skin hydration is significantly increased by a cream formulated to mimic the skin’s own natural moisturizing systems. Clin Cosmet Invest Dermatol. 2018;11:491–497. doi:10.2147/CCID.S177697
   Web of Science ®Google Scholar
• Marple B, Roland P, Benninger M. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg. 2004;130(1):131–141. doi:10.1016/j.otohns.2003.07.00514726922
   PubMed Web of Science ®Google Scholar
• Queckenberg C, Meins J, Wachall B, et al Absorption, pharmacokinetics, and safety of triclosan after dermal administration. Antimicrob Agents Chemother. 2010;54(1):570–572. doi:10.1128/AAC.00615-0919822703
   PubMed Web of Science ®Google Scholar
• Fisher AA. Contact Dermatitis. Chapter 12 3rd Philadelphia (US): Lea & Febiger; 1986:190–191.
   Google Scholar
• Jackson EM. Triclosan in leave-on products. Cosmet Dermatol. 1998;11:23–26.
   Google Scholar
• Bruckner-Tuderman L, Konig A, Schnyder UW. Patch test results of the dermatology clinic Zurich in 1989: personal computer aided statistical evaluation. Dermatology. 1992;184(1):29–33. doi:10.1159/0002474951558992
   PubMed Web of Science ®Google Scholar
• Chaptini C, Quinn S, Marshman G. Methicillin-resistant Staphylococcus aureus in children with atopic dermatitis from 1999 to 2014: a longitudinal study. Australas J Dermatol. 2016;57(2):122–127. doi:10.1111/ajd.1237126172088
   PubMed Web of Science ®Google Scholar
• Holland KT, Bojar RA, Cunliffe WJ. A Comparison of the Effect of Treatment of Atopic Eczema with and without Antimicrobial Compounds IN Round Table Series No. 37: the Bacteriology of Eczema. London: The Royal society of Medicine Press Limited; 1995:34–41.
   Google Scholar
• Harper J. Double Blind Comparison of an Antiseptic Oil-based Bath Additive (oilatum Plus) with Regular Oilatum (oilatum Emollient) for the Treatment of Atopic Eczema IN Round Table Series No. 37: the Bacteriology of Eczema. London: The Royal society of Medicine Press Limited; 1995:42–47.
   Google Scholar
• Tan WP, Suresh S, Tey HL, Chiam LY, Goon AT. A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis. Clin Exp Dermatol. 2010;35(4):e109–e112. doi:10.1111/j.1365-2230.2009.03719.x19843084
   PubMed Web of Science ®Google Scholar
• Wohlrab J, Jost G, Abeck D. Antiseptic efficacy of a low-dosed topical triclosan/chlorhexidine combination therapy in atopic dermatitis. Skin Pharmacol Physiol. 2007;20(2):71–76. doi:10.1159/00009765317143011
   PubMed Web of Science ®Google Scholar
• Gehring W, Forssman T, Jost G, Gloor M. The germ-reducing effect of erythromycin and triclosan in atopic dermatitis. Aktuelle Derm. 1996;22(1):28–31.
   Google Scholar
• Maarouf M, Shi VY. Bleach for atopic dermatitis. Dermatitis. 2018;29(3):120–126. doi:10.1097/DER.000000000000035829762205
   PubMed Web of Science ®Google Scholar
• Barnes TM, Greive KA. Use of bleach baths in the treatment of infected atopic eczema. Australas J Dermatol. 2013;54(4):251–258. doi:10.1111/ajd.1201523330843
   PubMed Web of Science ®Google Scholar